Quarterly report pursuant to Section 13 or 15(d)

Segments - Operations and Assets Information (Details)

v3.19.2
Segments - Operations and Assets Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Segment Reporting Information [Line Items]          
Total revenues $ 226,368 $ 263,685 $ 448,820 $ 518,598  
Operating loss (47,260) (5,108) (122,577) (47,719)  
Depreciation and amortization 23,661 24,762 47,477 49,518  
Net income (loss) from investment in investees (271) (7,213) (2,125) (9,669)  
Assets 2,456,228   2,456,228   $ 2,451,072
Goodwill 699,842   699,842   700,193
United States          
Segment Reporting Information [Line Items]          
Total revenues 184,310 222,535 369,203 437,845  
Ireland          
Segment Reporting Information [Line Items]          
Total revenues 22,174 20,778 42,707 38,060  
Chile          
Segment Reporting Information [Line Items]          
Total revenues 9,051 11,937 16,915 23,670  
Spain          
Segment Reporting Information [Line Items]          
Total revenues 4,876 4,592 9,294 10,125  
Israel          
Segment Reporting Information [Line Items]          
Total revenues 3,768 2,526 6,884 6,141  
Mexico          
Segment Reporting Information [Line Items]          
Total revenues 2,058 1,302 3,589 2,723  
Other          
Segment Reporting Information [Line Items]          
Total revenues 131 15 228 34  
Corporate          
Segment Reporting Information [Line Items]          
Operating loss (10,691) (8,748) (22,962) (20,393)  
Depreciation and amortization 19 21 39 51  
Net income (loss) from investment in investees 0 0 0 0  
Assets 78,217   78,217   52,413
Goodwill 0   0   0
Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Operating loss (8,556) 2,165 (38,033) (20,783)  
Depreciation and amortization 7,382 6,752 14,908 13,492  
Net income (loss) from investment in investees (271) (6,942) (2,125) (9,114)  
Assets 1,239,338   1,239,338   1,236,499
Goodwill 247,055   247,055   247,407
Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Operating loss (28,013) 1,475 (61,582) (6,543)  
Depreciation and amortization 16,260 17,989 32,530 35,975  
Net income (loss) from investment in investees 0 (271) 0 (555)  
Assets 1,138,673   1,138,673   1,162,160
Goodwill 452,787   452,787   $ 452,786
Services          
Segment Reporting Information [Line Items]          
Total revenues 178,458 216,055 357,349 427,369  
Services | Corporate          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Services | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Services | Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 178,458 216,055 357,349 427,369  
Products          
Segment Reporting Information [Line Items]          
Total revenues 28,680 28,523 53,981 56,374  
Products | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 28,680 28,523 53,981 56,374  
Transfer of intellectual property and other          
Segment Reporting Information [Line Items]          
Total revenues 19,230 19,107 37,490 34,855  
Transfer of intellectual property and other | Corporate          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Transfer of intellectual property and other | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 19,230 19,107 37,490 34,855  
Transfer of intellectual property and other | Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues $ 0 $ 0 $ 0 $ 0